Spansules Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 5.00 Cr
as on 16-11-2024
- Company Age 24 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 55.24 Cr
as on 16-11-2024
- Satisfied Charges ₹ 8.00 Cr
as on 16-11-2024
- Revenue 1.84%
(FY 2023)
- Profit 14.85%
(FY 2023)
- Ebitda 25.91%
(FY 2023)
- Net Worth 15.67%
(FY 2023)
- Total Assets 8.23%
(FY 2023)
About Spansules Pharmatech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹55.24 Cr. The company has closed loans amounting to ₹8.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venkata Guttikonda, Rama Guttikonda, Haswanth Guttikonda, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230TG2000PTC035421
- Company No.
035421
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Spansules Pharmatech Private Limited offer?
Spansules Pharmatech Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Pharmaceutical Pellets, Nutraceuticals & Dietary Supplements, Weight Loss Supplement.
Who are the key members and board of directors at Spansules Pharmatech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Guttikonda  | Managing Director | 09-Oct-2000 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Haswanth Guttikonda | Director | 07-Feb-2020 | Current |
| Rama Guttikonda | Director | 09-Oct-2000 | Current |
| Harika Guttikonda | Director | 07-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Spansules Pharmatech.
Spansules Pharmatech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.84% increase. The company also saw a substantial improvement in profitability, with a 14.85% increase in profit. The company's net worth Soared by an impressive increase of 15.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spansules Pharmatech?
In 2023, Spansules Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vyaghra Health Foods Private LimitedActive 8 years 12 daysHaswanth Guttikonda and Harika Guttikonda are mutual person
Spansules Formulations Private LimitedActive 9 years 7 monthsRama Guttikonda and Haswanth Guttikonda are mutual person
Int Cellulose LlpActive 5 years 11 monthsVenkata Guttikonda and Haswanth Guttikonda are mutual person
- Spansules Formulations India Private LimitedActive 2 years 9 months
Venkata Guttikonda, Rama Guttikonda and 2 more are mutual person
- Spansules Life Sciences Private LimitedActive 3 years 3 months
Venkata Guttikonda, Rama Guttikonda and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 May 2022 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 08 Feb 2022 | ₹24.77 Cr | Open |
Canara Bank Creation Date: 27 May 2015 | ₹0.80 M | Open |
How Many Employees Work at Spansules Pharmatech?
Spansules Pharmatech has a workforce of 52 employees as of May 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spansules Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spansules Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
